Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less

Journal of Clinical Oncology

Volumn 25, Issue 31, 2007, Pages 4946-4951

  Chi, Dennis S ^a   Ramirez, Pedro T ^a   Teitcher, Jerrold B ^a   Mironov, Svetlana ^a   Sarasohn, Debra M ^a   Iyer, Revathy B ^a   Eisenhauer, Eric L ^a   Abu Rustum, Nadeem R ^a   Sonoda, Yukio ^a   Levine, Douglas A ^a   Brown, Carol L ^a   Aghajanian, Carol ^a   Gershenson, David M ^a   Hoskins, William J ^a   Hricak, Hedvig ^a   Barakat, Richard R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OVARY CARCINOMA; PATIENT ASSESSMENT; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; FALLOPIAN TUBE NEOPLASMS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; NEOPLASM, RESIDUAL; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 36849043690     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.12.2317     Document Type: Article

References (15)

1. Bristow RE, Tomacruz RS, Armstrong DK, et al: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol 20:1248-1259, 2002
2. Chi DS, Eisenhauer EL, Lang J, et al: What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma? Gynecol Oncol 103:559-564, 2006
3. Ozols RF, Bundy BN, Greer BE, et al: Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A gynecologic oncology group study. J Clin Oncol 21:3194-3200, 2003
4. National Cancer Institute: Clinical Announcement: Intraperitoneal chemotherapy for ovarian cancer, 2006. http://ctep.cancer.gov/highlights/ clin_annc_010506.pdf
5. Armstrong DK, Bundy B, Wenzel L, et al: Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34-43, 2006
6. Nelson BE, Rosenfield AT, Schwartz PE: Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in ovarian carcinoma. J Clin Oncol 11:166-172, 1993
7. Bristow RE, Duska LR, Lambrou NC, et al: A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89:1532-1540, 2000
8. Axtell AE, Lee MH, Brisow RE, et al: Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol 25:384-389, 2007
9. Prefontaine M, Gelfand AG, Donavan JT, et al: Reproducibility of tumor measurements in ovarian cancer: A study of interobserver variability. Gynecol Oncol 66:87-90, 1994
10. Eisenkop SM, Spirtos NM, Lin WM: "Optimal" cytoreduction for advanced epithelial ovarian cancer: A commentary. Gynecol Oncol 103:329-335, 2006
11. Aletti GD, Dowdy SC, Podratz KC, et al: Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol Oncol 100:283-287, 2006
12. Coakley FV, Choi PH, Pothuri B, et al: Peritoneal metastases: Detection with spiral CT in patients with ovarian cancer. Radiology 223:495-499, 2002
13. de Bree ED, Koops W, Kroger R, et al: Peritoneal carcinomatosis from colorectal or appendiceal origin: Correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86:64-73, 2004
14. O'Connor AR, Coakley FV: Retained surgical materials in the postoperative abdomen and pelvis. Semin Ultrasound CT MR 25:290-302, 2004
15. Thiesse P, Ollivier L, DiStefano-Louineau D, et al: Response rate and accuracy in oncology trials: Reasons for interobserver variability. J Clin Oncol 15:3507-3514, 1997